Přehled o publikaci
2022
Cardiac sequelae after COVID-19: Results of a 1-year follow-up study with echocardiography and biomarkers
MATEJOVÁ, Gabriela; Martin RADVAN; Eliška BARTEČKOVÁ; Martin KAMENÍK; Lumír KOC et. al.Basic information
Original name
Cardiac sequelae after COVID-19: Results of a 1-year follow-up study with echocardiography and biomarkers
Authors
MATEJOVÁ, Gabriela; Martin RADVAN; Eliška BARTEČKOVÁ; Martin KAMENÍK; Lumír KOC; Jana HOŘÍNKOVÁ; Ľubica SÝKOROVÁ; Radka ŠTĚPÁNOVÁ and Petr KALA
Edition
Frontiers in Cardiovascular Medicine, Lausanne, Frontiers, 2022, 2297-055X
Other information
Language
English
Type of outcome
Article in a journal
Country of publisher
Switzerland
Confidentiality degree
is not subject to a state or trade secret
References:
Organization
Lékařská fakulta – Repository – Repository
UT WoS
000906974000001
EID Scopus
2-s2.0-85145507190
Keywords in English
COVID-19; SARS-CoV-2; echocardiography; troponin; NT-proBNP; survilence
Links
LX22NPO5107, research and development project.
Changed: 6/4/2023 04:59, RNDr. Daniel Jakubík
Abstract
V originále
lt; 0.001), while no right ventricle dysfunction was detected. There was very mild progress in left ventricle diastolic diameter [median (IQR) change 1.0 (−1.0; 4.0) mm; p = 0.001] between V1 and V3, mild enlargement of the left atrium (mean change 1.2 ± 4.17 mm; p = 0.021) and a non-significant trend to impairment of left ventricle diastolic dysfunction. There was a mild change in pulmonary artery systolic pressure [median (IQR) change 3.0 (−2.0; 8.0) mmHg; p = 0.038]. Conclusion: Despite a lot of information regarding cardiac impairment due to SARS-CoV2, our study does not suggest an increased risk for developing clinically significant heart changes during the 1-year follow-up. Based on our results, routine echocardiography and biomarkers collection is currently not recommended after COVID-19 recovery.
